Document:

Exhibit
10.23

 

AMENDMENT
NO. 2 TO

NON-QUALIFIED
STOCK OPTION AWARD AGREEMENT

UNDER
THE

BIORESTORATIVE
THERAPIES, INC.

2021
STOCK INCENTIVE PLAN

 

This
Amendment No. 2 to Non-Qualified Stock Option Award Agreement (this “Amendment”) is made and entered into as of December
10, 2021 (the “Effective Date”) by and between BioRestorative Therapies, Inc., a Delaware corporation (the “Company”),
and Francisco Silva (the “Participant”).

 

RECITALS

 

	A.	The
    Company granted to the Participant an option to purchase 1,173,917,974 shares of the Common Stock of the Company pursuant to the
    terms of a Non-Qualified Stock Option Award Agreement (the “Option”) under the BioRestorative Therapies, Inc.
    2021 Stock Incentive Plan (the “Plan”) on March 18, 2021 (the “Grant Date”).
	 	 
	B.	The
    Company effected a 1-for-4,000 reverse split of its Common Stock on October 27, 2021 (the “Reverse Split”).
	 	 
	C.	On
    November 4, 2021, the Company and the Participant entered into Amendment No. 1 to Non-Qualified Stock Option Award Agreement to amend
    the Exercise Price per Share in the Option to reflect the then current Fair Market Value, to indicate that the number of Option Shares
    (after giving effect to the Reverse Split) is 293,479 and to amend the vesting schedule.
	 	 
	D.	The
    Company wishes to amend the Exercise Price per Share in the Option to reflect the current Fair Market Value.
	 	 
	E.	The
    Company and the Participant wish to enter into this Amendment, pursuant to Section 18 of the Option, to amend and modify the Option
    by the terms of this Amendment and preserve the remaining terms of the Option without modification or amendment.
	 	 
	F.	This
    Amendment is subject to stockholder approval of an amendment to the Plan which grants authority to the Board of Directors of the
    Company or a committee thereof to reduce the Exercise Price per Share in the Option (“Stockholder Approval”).

 

 AMENDMENT

 

In
consideration of the above recitals, which are incorporated herein by reference, and the promises set forth in this Amendment and the
Option, and for other good and valuable consideration, the nature and sufficiency of which is hereby acknowledged, the parties hereby
agree as follows:

 

	1.	The
    Exercise Price per Share is hereby deleted and replaced with the following:
	 	 
	 	Exercise
    Price per Share:    $5.08
	 	 
	2.	The
    foregoing change to the Option is subject to Stockholder Approval. 
	 	 
	3.	Except
    as otherwise amended by this Amendment, all other provisions of the Option will remain unchanged and in full force and effect.

 

***Signature
Page to Follow***

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written.

 

	 	BIORESTORATIVE
    THERAPIES, INC.
	 	 	 
	 	By:	 
	 	 	Lance
Alstodt
	 	 	Chief
Executive Officer
	 	 	 
	 	PARTICIPANT
	 	 	 
	 	 
	 	Francisco Silva

 

***Signature
Page to Amendment No. 2 to Non-Qualified Stock Option Award Agreement***Exhibit
10.24

 

AMENDMENT
NO. 1 TO

NON-QUALIFIED
STOCK OPTION AWARD AGREEMENT

UNDER
THE

BIORESTORATIVE
THERAPIES, INC.

2021
STOCK INCENTIVE PLAN

 

This
Amendment No. 1 to Non-Qualified Stock Option Award Agreement (this “Amendment”) is made and entered into as of December
10, 2021 by and between BioRestorative Therapies, Inc., a Delaware corporation (the “Company”), and Nickolay Kukekov
(the “Participant”).

 

RECITALS

 

	A.	The
                                            Company granted to the Participant an option to purchase 25,236 shares of the Common Stock
                                            of the Company pursuant to the terms of a Non-Qualified Stock Option Award Agreement (the
                                            “Option”) under the BioRestorative Therapies, Inc. 2021 Stock Incentive
                                            Plan (the “Plan”) on November 4, 2021.
	 	 
	B.	The
                                            Company wishes to amend the Exercise Price per Share in the Option to reflect the current
                                            Fair Market Value.
	 	 
	C.	The
                                            Company and the Participant wish to enter into this Amendment, pursuant to Section 18 of
                                            the Option, to amend and modify the Option by the terms of this Amendment and preserve the
                                            remaining terms of the Option without modification or amendment.
	 	 
	D.	This
                                            Amendment is subject to stockholder approval of an amendment to the Plan which grants authority
                                            to the Board of Directors of the Company or a committee thereof to reduce the Exercise Price
                                            per Share in the Option (“Stockholder Approval”).

 

AMENDMENT

 

In
consideration of the above recitals, which are incorporated herein by reference, and the promises set forth in this Amendment and the
Option, and for other good and valuable consideration, the nature and sufficiency of which is hereby acknowledged, the parties hereby
agree as follows:

 

	1.	The
                                            Exercise Price per Share is hereby deleted and replaced with the following:
	 	 
	 	Exercise
                                            Price per Share:    $5.08
	 	 
	2.	The
                                            foregoing change to the Option is subject to Stockholder Approval.
	 	 
	3.	Except
                                            as otherwise amended by this Amendment, all other provisions of the Option will remain unchanged
                                            and in full force and effect.

 

***Signature
Page to Follow***

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written.

 

	 	BIORESTORATIVE
    THERAPIES, INC.
	 	 	 
	 	By:	 
	 	 	Lance
    Alstodt
	 	 	Chief
    Executive Officer
	 	 	 
	 	PARTICIPANT
	 	 	 
	 	 
	 	Nickolay
    Kukekov

 

***Signature
Page to Amendment No. 1 to Non-Qualified Stock Option Award Agreement***Exhibit
10.25

 

AMENDMENT
NO. 1 TO

NON-QUALIFIED
STOCK OPTION AWARD AGREEMENT

UNDER
THE

BIORESTORATIVE
THERAPIES, INC.

2021
STOCK INCENTIVE PLAN

 

This
Amendment No. 1 to Non-Qualified Stock Option Award Agreement (this “Amendment”) is made and entered into as of December
10, 2021 by and between BioRestorative Therapies, Inc., a Delaware corporation (the “Company”), and Patrick Williams
(the “Participant”).

 

RECITALS

 

	A.	The
                                            Company granted to the Participant an option to purchase 10,490 shares of the Common Stock
                                            of the Company pursuant to the terms of a Non-Qualified Stock Option Award Agreement (the
                                            “Option”) under the BioRestorative Therapies, Inc. 2021 Stock Incentive
                                            Plan (the “Plan”) on November 4, 2021.
	 	 
	B.	The
                                            Company wishes to amend the Exercise Price per Share in the Option to reflect the current
                                            Fair Market Value.
	 	 
	C.	The
                                            Company and the Participant wish to enter into this Amendment, pursuant to Section 18 of
                                            the Option, to amend and modify the Option by the terms of this Amendment and preserve the
                                            remaining terms of the Option without modification or amendment.
	 	 
	D.	This
                                            Amendment is subject to stockholder approval of an amendment to the Plan which grants authority
                                            to the Board of Directors of the Company or a committee thereof to reduce the Exercise Price
                                            per Share in the Option (“Stockholder Approval”).

 

 AMENDMENT

 

In
consideration of the above recitals, which are incorporated herein by reference, and the promises set forth in this Amendment and the
Option, and for other good and valuable consideration, the nature and sufficiency of which is hereby acknowledged, the parties hereby
agree as follows:

 

	1.	The
                                            Exercise Price per Share is hereby deleted and replaced with the following:
	 	 
	 	Exercise
Price per Share:    $5.08
	 	 
	2.	The
                                            foregoing change to the Option is subject to Stockholder Approval.
	 	 
	3.	Except
                                            as otherwise amended by this Amendment, all other provisions of the Option will remain unchanged
                                            and in full force and effect.

 

***Signature
Page to Follow***

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written.

 

	 	BIORESTORATIVE
    THERAPIES, INC.
	 	 	 
	 	By:	 
	 	 	Lance
Alstodt
	 	 	Chief
Executive Officer
	 	 	 
	 	PARTICIPANT
	 	 	 
	 	 
	 	Patrick Williams

 

***Signature
Page to Amendment No. 1 to Non-Qualified Stock Option Award Agreement***Exhibit
10.26

 

AMENDMENT
NO. 1 TO

NON-QUALIFIED
STOCK OPTION AWARD AGREEMENT

UNDER
THE

BIORESTORATIVE
THERAPIES, INC.

2021
STOCK INCENTIVE PLAN

 

This
Amendment No. 1 to Non-Qualified Stock Option Award Agreement (this “Amendment”) is made and entered into as of December
10, 2021 by and between BioRestorative Therapies, Inc., a Delaware corporation (the “Company”), and David Rosa (the
“Participant”).

 

RECITALS

 

	A.	The
    Company granted to the Participant an option to purchase 10,490 shares of the Common Stock of the Company pursuant to the terms of
    a Non-Qualified Stock Option Award Agreement (the “Option”) under the BioRestorative Therapies, Inc. 2021 Stock
    Incentive Plan (the “Plan”) on November 4, 2021.
	 	 
	B.	The
    Company wishes to amend the Exercise Price per Share in the Option to reflect the current Fair Market Value.
	 	 
	C.	The
    Company and the Participant wish to enter into this Amendment, pursuant to Section 18 of the Option, to amend and modify the Option
    by the terms of this Amendment and preserve the remaining terms of the Option without modification or amendment.
	 	 
	D.
    	This
    Amendment is subject to stockholder approval of an amendment to the Plan which grants authority to the Board of Directors of the
    Company or a committee thereof to reduce the Exercise Price per Share in the Option (“Stockholder Approval”).

 

 AMENDMENT

 

In
consideration of the above recitals, which are incorporated herein by reference, and the promises set forth in this Amendment and the
Option, and for other good and valuable consideration, the nature and sufficiency of which is hereby acknowledged, the parties hereby
agree as follows:

 

	1.	The
    Exercise Price per Share is hereby deleted and replaced with the following:
	 	 
	 	Exercise
    Price per Share: $5.08
	 	 
	2.	The
    foregoing change to the Option is subject to Stockholder Approval.
	 	 
	3.	Except
    as otherwise amended by this Amendment, all other provisions of the Option will remain unchanged and in full force and effect.

 

***Signature
Page to Follow***

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written.

 

	 	BIORESTORATIVE
    THERAPIES, INC.
	 	 	 
	 	By:	 
	 	 	Lance
    Alstodt
	 	 	Chief
    Executive Officer
	 	 	 
	 	PARTICIPANT
	 	 	 
	 	 
	 	David Rosa

 

***Signature
Page to Amendment No. 1 to Non-Qualified Stock Option Award Agreement***

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]